Monoclonal Antibodies in the News
- Recombinant Monoclonal Antibody Market Outlook 2026-2033: - openPR.com
- A Novel CCR5 Antagonist for Multiple Therapeutic Applications - the-scientist.com
- Monoclonal Antibodies in the Pathogenesis of Heparin-Induced Thrombocytopenia | New England Journal of Medicine - The New England Journal of Medicine
- Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial - Nature
- Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease - BioSpace
©
2026
MAb Technologies | monoclonal antibodies to transporter proteins
Website by 3by400, North Georgia web design team using Joomla!
Website by 3by400, North Georgia web design team using Joomla!